Theo Manschreck to Schizophrenic Psychology
This is a "connection" page, showing publications Theo Manschreck has written about Schizophrenic Psychology.
Connection Strength
3.075
-
Manschreck TC, Merrill AM, Jabbar G, Chun J, Delisi LE. Frequency of normative word associations in the speech of individuals at familial high-risk for schizophrenia. Schizophr Res. 2012 Sep; 140(1-3):99-103.
Score: 0.482
-
Manschreck TC, Maher BA, Candela SF, Redmond D, Yurgelun-Todd D, Tsuang M. Impaired verbal memory is associated with impaired motor performance in schizophrenia: relationship to brain structure. Schizophr Res. 2000 May 25; 43(1):21-32.
Score: 0.208
-
Manschreck TC, Maher BA, Winzig L, Candela SF, Beaudette S, Boshes R. Age disorientation in schizophrenia: an indicator of progressive and severe psychopathology, not institutional isolation. J Neuropsychiatry Clin Neurosci. 2000; 12(3):350-8.
Score: 0.202
-
Boshes RA, Manschreck TC. Less is more Redux: Scheduled intermittent dosing to protect/prevent cognitive deterioration in schizophrenia. Med Hypotheses. 2016 May; 90:79-81.
Score: 0.155
-
Manschreck TC, Redmond DA, Beaudette SM. Clozapine in the back wards. Ann Clin Psychiatry. 1994 Dec; 6(4):215-25.
Score: 0.142
-
Thermenos HW, Whitfield-Gabrieli S, Seidman LJ, Kuperberg G, Juelich RJ, Divatia S, Riley C, Jabbar GA, Shenton ME, Kubicki M, Manschreck T, Keshavan MS, DeLisi LE. Altered language network activity in young people at familial high-risk for schizophrenia. Schizophr Res. 2013 Dec; 151(1-3):229-37.
Score: 0.132
-
Boshes RA, Manschreck TC, Konigsberg W. Genetics of the schizophrenias: a model accounting for their persistence and myriad phenotypes. Harv Rev Psychiatry. 2012 May-Jun; 20(3):119-29.
Score: 0.119
-
Manschreck TC, Leighton AH. Reducing disability in mood disorders and schizophrenia. Hosp Community Psychiatry. 1992 Feb; 43(2):179-80.
Score: 0.117
-
Manschreck TC, Maher BA, Rosenthal JE, Berner J. Reduced primacy and related features in schizophrenia. Schizophr Res. 1991 Jul-Aug; 5(1):35-41.
Score: 0.112
-
Stroup TS, Appelbaum PS, Gu H, Hays S, Swartz MS, Keefe RS, Kim SY, Manschreck TC, Boshes RA, McEvoy JP, Lieberman JA. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study. Schizophr Res. 2011 Aug; 130(1-3):47-52.
Score: 0.111
-
Manschreck TC, Maher B, Celada MT, Schneyer M, Fernandez R. Object chaining and thought disorder in schizophrenic speech. Psychol Med. 1991 May; 21(2):443-6.
Score: 0.111
-
Manoach DS, Maher BA, Manschreck TC. Left-handedness and though disorder in the schizophrenias. J Abnorm Psychol. 1988 Feb; 97(1):97-9.
Score: 0.088
-
Manschreck TC, Maher BA, Milavetz JJ, Ames D, Weisstein CC, Schneyer ML. Semantic priming in thought disordered schizophrenic patients. Schizophr Res. 1988 Jan-Feb; 1(1):61-6.
Score: 0.088
-
Manschreck TC, Boshes RA. The CATIE schizophrenia trial: results, impact, controversy. Harv Rev Psychiatry. 2007 Sep-Oct; 15(5):245-58.
Score: 0.086
-
Lenzenweger MF, Miller AB, Maher BA, Manschreck TC. Schizotypy and individual differences in the frequency of normal associations in verbal utterances. Schizophr Res. 2007 Sep; 95(1-3):96-102.
Score: 0.085
-
Manschreck TC, Ames D, Maher BA, Schneyer ML. Impoverished written responses and negative features of schizophrenia. Percept Mot Skills. 1987 Jun; 64(3 Pt 2):1163-9.
Score: 0.084
-
Goff DC, Lamberti JS, Leon AC, Green MF, Miller AL, Patel J, Manschreck T, Freudenreich O, Johnson SA. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology. 2008 Feb; 33(3):465-72.
Score: 0.084
-
Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology. 2006 Sep; 31(9):2033-46.
Score: 0.078
-
Manschreck TC, Ames D. Neurologic features and psychopathology in schizophrenic disorders. Biol Psychiatry. 1984 May; 19(5):703-19.
Score: 0.068
-
Manschreck TC. Psychopathology of motor behavior in schizophrenia. Prog Exp Pers Res. 1983; 12:53-99.
Score: 0.062
-
Manschreck TC, Maher BA, Rucklos ME, Vereen DR, Ader DN. Deficient motor synchrony in schizophrenia. J Abnorm Psychol. 1981 Aug; 90(4):321-8.
Score: 0.056
-
Manschreck TC, Maher BA, Ader DN. Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia. Br J Psychiatry. 1981 Jul; 139:7-15.
Score: 0.056
-
Manschreck TC, Maher BA, Rucklos ME, White MT. The predictability of thought disordered speech in schizophrenic patients. Br J Psychiatry. 1979 Jun; 134:595-601.
Score: 0.048
-
Manschreck TC, Redmond DA, Candela SF, Maher BA. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia. J Neuropsychiatry Clin Neurosci. 1999; 11(4):481-9.
Score: 0.047
-
Manschreck TC, Maher BA, Beaudette SM, Redmond DA. Context memory in schizoaffective and schizophrenic disorders. Schizophr Res. 1997 Aug 29; 26(2-3):153-61.
Score: 0.043
-
Maher BA, Manschreck TC, Redmond D, Beaudette S. Length of illness and the gradient from positive to negative semantic priming in schizophrenic patients. Schizophr Res. 1996 Nov 15; 22(2):127-32.
Score: 0.041
-
Maher BA, Manschreck TC, Woods BT, Yurgelun-Todd DA, Tsuang MT. Frontal brain volume and context effects in short-term recall in schizophrenia. Biol Psychiatry. 1995 Feb 01; 37(3):144-50.
Score: 0.036
-
Goff DC, McEvoy JP, Citrome L, Mech AW, Bustillo JR, Gil R, Buckley P, Manschreck TC, Achtyes ED, Macklin EA. High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study. J Clin Psychopharmacol. 2013 Aug; 33(4):485-90.
Score: 0.032
-
Manschreck TC, Maher BA, Waller NG, Ames D, Latham CA. Deficient motor synchrony in schizophrenic disorders: clinical correlates. Biol Psychiatry. 1985 Sep; 20(9):990-1002.
Score: 0.019
-
Manschreck TC, Maher BA, Hoover TM, Ames D. The type--token ratio in schizophrenic disorders: clinical and research value. Psychol Med. 1984 Feb; 14(1):151-7.
Score: 0.017
-
Maher BA, Manschreck TC, Molino MA. Redundancy, pause distributions and thought disorder in schizophrenia. Lang Speech. 1983 Apr-Jun; 26 ( Pt 2):191-9.
Score: 0.016
-
Manschreck TC, Maher BA, Rucklos ME, Vereen DR. Disturbed voluntary motor activity in schizophrenic disorder. Psychol Med. 1982 Feb; 12(1):73-84.
Score: 0.015
-
Maher BA, Manschreck TC, Rucklos ME. Contextual constraint and the recall of verbal material in schizophrenia: the effect of thought disorder. Br J Psychiatry. 1980 Jul; 137:69-73.
Score: 0.013
-
Manschreck TC. The assessment of paranoid features. Compr Psychiatry. 1979 Jul-Aug; 20(4):370-7.
Score: 0.012
-
Blyler CR, Maher BA, Manschreck TC, Fenton WS. Line drawing as a possible measure of lateralized motor performance in schizophrenia. Schizophr Res. 1997 Jul 25; 26(1):15-23.
Score: 0.011